Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corcept Therapeutics Inc (CORT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Corcept Therapeutics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1088856.
Total stock buying since 2015: $16,587,167.
Total stock sales since 2015: $267,932,300.
Total stock option exercises since 2015: $48,172,878.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 100,000 | $3,328,300 | 509,035 | $33,794,280 | 805,000 | $9,213,909 |
| 2025 | 0 | $0 | 1,172,404 | $95,460,962 | 1,948,000 | $15,155,010 |
| 2024 | 0 | $0 | 296,371 | $9,319,822 | 453,250 | $3,366,620 |
| 2023 | 0 | $0 | 260,248 | $7,330,817 | 382,163 | $1,538,339 |
| 2022 | 0 | $0 | 572,130 | $14,797,253 | 1,505,425 | $3,818,217 |
| 2021 | 150,000 | $3,229,500 | 412,889 | $10,207,362 | 1,872,389 | $7,415,257 |
| 2020 | 93,510 | $1,443,991 | 70,000 | $1,374,020 | 158,984 | $687,499 |
| 2019 | 0 | $0 | 60,000 | $705,330 | 1,282,885 | $1,963,032 |
| 2018 | 631,159 | $8,042,877 | 420,115 | $7,612,616 | 450,115 | $926,946 |
| 2017 | 5,600 | $54,588 | 4,187,955 | $39,149,739 | 61,006 | $160,382 |
| 2016 | 100,000 | $487,911 | 3,401,164 | $31,369,433 | 1,188,812 | $1,820,804 |
| 2015 | 0 | $0 | 3,010,311 | $16,810,666 | 822,437 | $2,106,863 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-07 | Fishman Robert S (Chief Medical Officer) | Sale | 8,000 | 16.60 | 132,776 |
| 2018-02-07 | Fishman Robert S (Chief Medical Officer) | Option Ex | 8,000 | 3.51 | 28,080 |
| 2018-01-08 | Fishman Robert S (Chief Medical Officer) | Sale | 8,000 | 18.67 | 149,352 |
| 2018-01-08 | Fishman Robert S (Chief Medical Officer) | Option Ex | 8,000 | 3.51 | 28,080 |
| 2017-12-08 | Fishman Robert S (Chief Medical Officer) | Sale | 8,000 | 16.72 | 133,776 |
| 2017-12-08 | Fishman Robert S (Chief Medical Officer) | Option Ex | 8,000 | 3.51 | 28,080 |
| 2017-11-13 | Baker G Leonard Jr (Director) | Sale | 30,000 | 17.59 | 527,550 |
| 2017-11-13 | Baker G Leonard Jr (Director) | Option Ex | 30,000 | 2.70 | 81,000 |
| 2017-07-19 | Mahoney David L (Director) | Sale | 16,915 | 12.50 | 211,454 |
| 2017-07-19 | Mahoney David L (Director) | Option Ex | 16,915 | 2.23 | 37,720 |
| 2017-07-18 | Mahoney David L (Director) | Sale | 6,091 | 12.50 | 76,137 |
| 2017-07-18 | Mahoney David L (Director) | Option Ex | 6,091 | 2.23 | 13,582 |
| 2017-07-13 | Mahoney David L (Director) | Sale | 484 | 12.55 | 6,073 |
| 2017-07-12 | Mahoney David L (Director) | Sale | 6,510 | 12.50 | 81,375 |
| 2017-05-04 | Robb Gary Charles (Chief Financial Officer) | Buy | 5,600 | 9.75 | 54,588 |
| 2017-03-16 | Enright Patrick G (Director) | Sale | 269,955 | 9.94 | 2,683,082 |
| 2017-03-15 | Enright Patrick G (Director) | Sale | 279,020 | 10.24 | 2,856,606 |
| 2017-03-14 | Enright Patrick G (Director) | Sale | 300,000 | 10.01 | 3,002,700 |
| 2017-03-13 | Enright Patrick G (Director) | Sale | 20,980 | 11.13 | 233,486 |
| 2017-03-08 | Enright Patrick G (Director) | Sale | 750,000 | 9.75 | 7,312,500 |
| 2017-02-27 | Enright Patrick G (Director) | Sale | 1,000,000 | 9.05 | 9,050,000 |
| 2017-02-23 | Enright Patrick G (Director) | Sale | 1,500,000 | 8.65 | 12,975,000 |
| 2016-11-25 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 14,741 | 9.39 | 138,373 |
| 2016-11-25 | Enright Patrick G (Director) | Sale | 14,741 | 9.39 | 138,373 |
| 2016-11-23 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 12,600 | 9.30 | 117,230 |
| 2016-11-23 | Enright Patrick G (Director) | Sale | 12,600 | 9.30 | 117,230 |
| 2016-11-22 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 9,600 | 9.33 | 89,568 |
| 2016-11-22 | Enright Patrick G (Director) | Sale | 9,600 | 9.33 | 89,568 |
| 2016-11-21 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 118,385 | 9.39 | 1,111,161 |
| 2016-11-21 | Enright Patrick G (Director) | Sale | 118,385 | 9.39 | 1,111,161 |
| 2016-11-18 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 100,562 | 9.47 | 952,724 |
| 2016-11-18 | Enright Patrick G (Director) | Sale | 100,562 | 9.47 | 952,724 |
| 2016-11-17 | Longitude Capital Associates, L.p. (10% Owner) | Sale | 325,153 | 9.64 | 3,135,450 |
| 2016-11-17 | Enright Patrick G (Director) | Sale | 325,153 | 9.64 | 3,135,450 |
| 2016-11-16 | Tammenoms Bakker Juliet (10% Owner) | Sale | 52,182 | 9.51 | 496,197 |
| 2016-11-16 | Enright Patrick G (Director) | Sale | 17,394 | 9.51 | 165,399 |
| 2016-11-15 | Tammenoms Bakker Juliet (10% Owner) | Sale | 472,359 | 9.55 | 4,512,444 |
| 2016-11-15 | Enright Patrick G (Director) | Sale | 157,453 | 9.55 | 1,504,148 |
| 2016-11-11 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Sale | 200,000 | 9.10 | 1,820,400 |
| 2016-11-11 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Option Ex | 200,000 | 1.50 | 300,000 |
| 2016-11-11 | Wilson James N (Director) | Sale | 14,216 | 9.10 | 129,394 |
| 2016-11-11 | Wilson James N (Director) | Option Ex | 14,216 | 1.51 | 21,466 |
| 2016-11-11 | Mahoney David L (Director) | Sale | 30,000 | 9.35 | 280,500 |
| 2016-11-11 | Mahoney David L (Director) | Option Ex | 30,000 | 2.70 | 81,000 |
| 2016-11-10 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Sale | 300,000 | 8.90 | 2,670,600 |
| 2016-11-10 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Option Ex | 300,000 | 1.50 | 450,000 |
| 2016-11-10 | Wilson James N (Director) | Sale | 33,247 | 8.90 | 295,964 |
| 2016-11-10 | Wilson James N (Director) | Option Ex | 33,247 | 1.51 | 50,202 |
| 2016-11-09 | Wilson James N (Director) | Sale | 111,349 | 8.32 | 926,869 |
| 2016-11-09 | Wilson James N (Director) | Option Ex | 111,349 | 1.51 | 168,136 |
| 2016-11-07 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Sale | 500,000 | 8.27 | 4,136,500 |
| 2016-11-07 | Belanoff Joseph K (CHIEF EXECUTIVE OFFICER) | Option Ex | 500,000 | 1.50 | 750,000 |
| 2016-05-10 | Baker G Leonard Jr (Director) | Buy | 29,498 | 5.00 | 147,637 |
| 2016-05-09 | Baker G Leonard Jr (Director) | Buy | 26,302 | 4.88 | 128,380 |
| 2016-05-06 | Baker G Leonard Jr (Director) | Buy | 44,200 | 4.79 | 211,894 |
| 2016-01-06 | Wilson James N (Director) | Sale | 1,188 | 2.45 | 2,912 |
| 2015-12-10 | Bradbury Daniel (Director) | Sale | 10,000 | 4.88 | 48,810 |
| 2015-12-09 | Bradbury Daniel (Director) | Sale | 10,000 | 4.81 | 48,120 |
| 2015-12-01 | Wilson James N (Director) | Sale | 10,000 | 2.60 | 26,000 |
| 2015-12-01 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-11-24 | Bradbury Daniel (Director) | Sale | 10,000 | 5.10 | 51,020 |
| 2015-11-23 | Bradbury Daniel (Director) | Sale | 30,000 | 4.96 | 148,920 |
| 2015-11-16 | Lo Steven (SVP Oncology) | Option Ex | 585,416 | 2.74 | 1,605,796 |
| 2015-11-12 | Wilson James N (Director) | Sale | 20,000 | 2.45 | 49,000 |
| 2015-11-12 | Wilson James N (Director) | Option Ex | 20,000 | 1.51 | 30,200 |
| 2015-11-02 | Lo Steven (VP Commercial Operations) | Sale | 12,500 | 4.00 | 50,000 |
| 2015-10-26 | Lo Steven (VP Commercial Operations) | Option Ex | 12,500 | 3.29 | 41,125 |
| 2015-10-13 | Lo Steven (VP Commercial Operations) | Sale | 53,033 | 3.82 | 202,586 |
| 2015-10-07 | Lo Steven (VP Commercial Operations) | Sale | 5,300 | 4.00 | 21,200 |
| 2015-10-06 | Lo Steven (VP Commercial Operations) | Sale | 50,000 | 3.76 | 188,000 |
| 2015-09-29 | Lo Steven (VP Commercial Operations) | Option Ex | 108,333 | 2.70 | 292,499 |
| 2015-09-28 | Ledoux Anne M (VP & Controller) | Option Ex | 25,000 | 1.19 | 29,750 |
| 2015-09-16 | Bradbury Daniel (Director) | Sale | 10,000 | 4.91 | 49,080 |
| 2015-09-15 | Bradbury Daniel (Director) | Sale | 10,000 | 5.00 | 50,050 |
| 2015-09-01 | Wilson James N (Director) | Sale | 10,000 | 2.45 | 24,500 |
| 2015-09-01 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-08-27 | Bradbury Daniel (Director) | Sale | 10,000 | 4.99 | 49,900 |
| 2015-08-26 | Bradbury Daniel (Director) | Sale | 10,000 | 4.54 | 45,350 |
| 2015-08-05 | Wilson James N (Director) | Sale | 4,100 | 2.45 | 10,045 |
| 2015-08-05 | Wilson James N (Director) | Option Ex | 4,100 | 1.51 | 6,191 |
| 2015-08-04 | Wilson James N (Director) | Sale | 2,900 | 4.90 | 14,210 |
| 2015-08-04 | Wilson James N (Director) | Option Ex | 2,900 | 1.51 | 4,379 |
| 2015-08-03 | Wilson James N (Director) | Sale | 3,000 | 4.97 | 14,904 |
| 2015-08-03 | Wilson James N (Director) | Option Ex | 3,000 | 1.51 | 4,530 |
| 2015-07-21 | Bradbury Daniel (Director) | Sale | 10,000 | 4.98 | 49,800 |
| 2015-07-20 | Bradbury Daniel (Director) | Sale | 10,000 | 5.32 | 53,200 |
| 2015-07-08 | Mahoney David L (Director) | Sale | 33,828 | 5.74 | 194,071 |
| 2015-07-01 | Wilson James N (Director) | Sale | 10,000 | 3.03 | 30,280 |
| 2015-07-01 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-06-24 | Bradbury Daniel (Director) | Sale | 10,000 | 6.57 | 65,700 |
| 2015-06-23 | Bradbury Daniel (Director) | Sale | 10,000 | 6.92 | 69,200 |
| 2015-06-02 | Wilson James N (Director) | Sale | 10,000 | 6.13 | 61,340 |
| 2015-06-02 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-05-04 | Wilson James N (Director) | Sale | 10,000 | 5.92 | 59,200 |
| 2015-05-04 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-04-01 | Wilson James N (Director) | Sale | 10,000 | 5.60 | 56,000 |
| 2015-04-01 | Wilson James N (Director) | Option Ex | 10,000 | 1.51 | 15,100 |
| 2015-03-24 | Tammenoms Bakker Juliet | Sale | 554,348 | 5.65 | 3,132,066 |
| 2015-03-24 | Enright Patrick G | Sale | 554,348 | 5.65 | 3,132,066 |
| 2015-03-20 | Tammenoms Bakker Juliet | Sale | 535,397 | 5.85 | 3,132,072 |
| 2015-03-20 | Enright Patrick G | Sale | 535,397 | 5.85 | 3,132,072 |
| 2015-03-20 | Wilson James N (Director) | Sale | 8,359 | 5.85 | 48,900 |
| 2015-03-20 | Mahoney David L (Director) | Sale | 31,175 | 5.85 | 182,373 |
| 2015-03-20 | Baker G Leonard Jr (Director) | Sale | 314,356 | 5.85 | 1,838,982 |
| 2015-03-19 | Cook Joseph C Jr (Director) | Sale | 92,270 | 5.22 | 481,649 |
| 2015-01-04 | Wilson James N (Director) | Option Ex | 1,188 | 1.51 | 1,793 |
Insider trading activities including stock purchases, stock sales, and option exercises of CORT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Corcept Therapeutics Inc (symbol CORT, CIK number 1088856) see the Securities and Exchange Commission (SEC) website.